May 9, 2025, 16:18

Damon Runyon Fellowship Award

The Damon Runyon Cancer Research Foundation is now accepting applications for its 2025 Postdoctoral Fellowship Award, a prestigious four-year program designed to support early-career scientists conducting innovative basic or translational cancer research. This award is one of the most competitive fellowships in cancer science, providing not only generous funding but also mentorship, networking, and debt relief for physician-scientists.

Who is eligible?

Applicants must:

Hold a PhD, MD, DO, DVM, DDS, or equivalent degree
Not have accepted another postdoctoral fellowship award (T32 accepted at time of application, but not concurrently)
Work under a Sponsor in a tenured/tenure-track position in the U.S.
Apply within 3 years of receiving their doctoral degree (Level 1), or within 2 years of ending clinical training (Level 2)
Not continue training in the lab where they earned their PhD or extend their graduate work
Submit a complete application via ProposalCentral

Funding at a glance:

Four-year term, contingent on annual progress
Stipend ranges from 70,000 USD to 76,000 USD /year
2,000 USD /year expense allowance
1,000 USD /year per dependent child
Up to 100,000 USD in medical school loan repayment (for MDs)
Access to retreats, mentoring, and exclusive awards like:
- Jake Wetchler Award for Pediatric Innovation (10,000 USD)
- Dale F. Frey Award for Breakthrough Scientists

Key deadlines:

Spring Deadline: March 17, 2025 (for July–October 2025 start)
- For applicants whose degree was awarded between Sept 15, 2023 and March 17, 2025
Fall Deadline: August 15, 2025 (for Jan–April 2026 start)
- For applicants whose degree was awarded between Feb 15, 2024 and Aug 15, 2025
Selection Dates: May 2, 2025 (spring), November 7, 2025 (fall)

Required materials:

Sponsor’s letter, biosketch, and training plan
Applicant’s biosketch, research proposal (max 5 pages), personal and commitment statements
Summary of research (1 page)
Full bibliography (hyperlinked), copy of diploma
3 reference letters (including one from PhD advisor for PhD applicants)
Optional: 1–2 collaborator letters

Contact:

Email: [email protected]

More info: www.damonrunyon.org

biomedical research cancer funding Cancer research Damon Runyon Early-career researchers MD PhD OncoDaily Pediatric cancer physician-scientist Postdoctoral Fellowship proposalCENTRAL Scientific innovation Translational Oncology

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

Who From Oncology is Featured in TIME100 Health 2025?

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot